We provide here broad genetic, clinical, and functional evidence firmly establishing RASAL1 as a prominent general human tumor suppressor gene, whose alterations play a robust role in cancer aggressiveness through overactivating the PI3K pathway, particularly when uniquely concurrent with PTEN alterations. The gene discussed is PTEN; the disease is neoplasm.